These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15668949)

  • 1. Complexation of celecoxib with beta-cyclodextrin: characterization of the interaction in solution and in solid state.
    Sinha VR; Anitha R; Ghosh S; Nanda A; Kumria R
    J Pharm Sci; 2005 Mar; 94(3):676-87. PubMed ID: 15668949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterization and in vitro dissolution behaviour of celecoxib-beta-cyclodextrin inclusion complexes.
    Sinha VR; Anitha R; Ghosh S; Amita ; Kumria R; Bhinge JR; Kumar M
    Acta Pharm; 2007 Mar; 57(1):47-60. PubMed ID: 19839406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR; Nanda A; Chadha R; Goel H
    Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
    Rawat S; Jain SK
    Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies.
    Reddy MN; Rehana T; Ramakrishna S; Chowdhary KP; Diwan PV
    AAPS PharmSci; 2004 Mar; 6(1):E7. PubMed ID: 15198508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the inclusion complex between beta-cyclodextrin and celecoxib by spectrofluorimetry and its analytical application.
    Manzoori JL; Abdolmohammad-Zadeh H; Amjadi M
    Farmaco; 2005; 60(6-7):575-81. PubMed ID: 15925366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of zaleplon complexation with cyclodextrins and hydrophilic polymers in solution and in solid state.
    Jablan J; Szalontai G; Jug M
    J Pharm Biomed Anal; 2012 Dec; 71():35-44. PubMed ID: 22898722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study.
    Ventura CA; Giannone I; Paolino D; Pistarà V; Corsaro A; Puglisi G
    Eur J Med Chem; 2005 Jul; 40(7):624-31. PubMed ID: 15935897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on trimethoprim:hydroxypropyl-β-cyclodextrin: aggregate and complex formation.
    Garnero C; Zoppi A; Genovese D; Longhi M
    Carbohydr Res; 2010 Nov; 345(17):2550-6. PubMed ID: 20933225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
    Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of ascorbic acid interaction with hydroxypropyl-beta-cyclodextrin and triethanolamine, separately and in combination.
    Garnero C; Longhi M
    J Pharm Biomed Anal; 2007 Nov; 45(4):536-45. PubMed ID: 17851014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl beta-cyclodextrin.
    Chowdary KP; Srinivas SV
    AAPS PharmSciTech; 2006 Sep; 7(3):79. PubMed ID: 17025259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diclofenac-beta-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies.
    Manca ML; Zaru M; Ennas G; Valenti D; Sinico C; Loy G; Fadda AM
    AAPS PharmSciTech; 2005 Oct; 6(3):E464-72. PubMed ID: 16354006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.